Flash glucose monitoring system: impact on glycemic control and body mass index in type 1 diabetes mellitus

• DOI: 10.20945/2359-3997000000405
• Publication Date: 2021-09-30T21:09:50Z
• Authors: Juliana Marques Sá; Sara Campos Lopes; Mariana Barbosa; Inês Ferreira Barros; Maria Joana Santos
• Keywords: Adult; Blood Glucose; type 1 diabetes; flash glucose monitoring; body mass index; Glycemic Control; Diseases of the endocrine glands. Clinical endocrinology; Body Mass Index; 03 medical and health sciences; 0302 clinical medicine; Humans; Hypoglycemic Agents; Insulin; Retrospective Studies; Glycated Hemoglobin; 2. Zero hunger; Blood Glucose Self-Monitoring; Diabetes; R; RC648-665; 3. Good health; Diabetes Mellitus, Type 1; Medicine; Original Article; glycated hemoglobin

Flash glucose monitoring (FGM) is increasingly used in type 1 diabetes mellitus (T1D) management. This study aimed to assess glycated hemoglobin (HbA1c) and body mass index (BMI) the first year of FGM use patients with T1D identify predictive factors benefit associated its use.Retrospective patients, using for ≥ 6 months under intensive insulin therapy multiple daily injections.In 179 a median (Md) age 43.0 years (P25 31.0; P75 52.0) disease duration 18.0 10.0; 28.0), initial HbA1c was 7.9% 7.2; 8.8) BMI 24.0 kg/m2 21.9; 26.2). With FGM, improved significantly 7.6% 7.0; 8.3) at 7.7% 6.95; 8.5) 12 (p < 0.05), more 7% (16.1% vs 22.5%) fewer 8% (49.1% 35.8%) 0.05). Initial 8.0-8.9% (HR 1.886; 95% CI 1.321-2.450) 9.0% 3.108, 2.454-3.761) predicted greater reduction. increased significantly, especially between (BMI Md 23.8 [P25 26.2] 22.0; kg/m2, respectively) Overweight 4.319, 3.185-5.453) obesity 8.112, 3.919-12.306) weight gain.FGM significant improvement HbA1c, mainly worse previous glycemic control. It also BMI, if baseline 25 so control strategies should be emphasized.